- Home
- GCTS vs MIST Comparison
GCTS vs MIST Comparison
Compare GCTS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- MIST
- Stock Information
- Founded
- GCTS 1998
- MIST 2003
- Country
- GCTS United States
- MIST Canada
- Employees
- GCTS N/A
- MIST N/A
- Industry
- GCTS Blank Checks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- GCTS Finance
- MIST Health Care
- Exchange
- GCTS Nasdaq
- MIST Nasdaq
- Market Cap
- GCTS 102.6M
- MIST 103.4M
- IPO Year
- GCTS N/A
- MIST N/A
- Fundamental
- Price
- GCTS $2.02
- MIST $2.04
- Analyst Decision
- GCTS Strong Buy
- MIST Strong Buy
- Analyst Count
- GCTS 1
- MIST 3
- Target Price
- GCTS $5.00
- MIST $13.00
- AVG Volume (30 Days)
- GCTS 116.8K
- MIST 846.8K
- Earning Date
- GCTS 04-03-2025
- MIST 03-20-2025
- Dividend Yield
- GCTS N/A
- MIST N/A
- EPS Growth
- GCTS N/A
- MIST N/A
- EPS
- GCTS N/A
- MIST N/A
- Revenue
- GCTS $11,532,000.00
- MIST N/A
- Revenue This Year
- GCTS N/A
- MIST N/A
- Revenue Next Year
- GCTS $463.17
- MIST N/A
- P/E Ratio
- GCTS N/A
- MIST N/A
- Revenue Growth
- GCTS N/A
- MIST N/A
- 52 Week Low
- GCTS $1.97
- MIST $1.12
- 52 Week High
- GCTS $56.00
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- GCTS 40.86
- MIST 45.68
- Support Level
- GCTS $1.97
- MIST $2.20
- Resistance Level
- GCTS $2.36
- MIST $2.38
- Average True Range (ATR)
- GCTS 0.14
- MIST 0.13
- MACD
- GCTS 0.00
- MIST -0.01
- Stochastic Oscillator
- GCTS 13.92
- MIST 33.33
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).